NIH-funded research R01 grant

Reducing liver cholesterol production using a new small molecule

Official title: Inhibition of hepatic (V)LDL production by a novel antagonist of carboxyl esterase 1

Funded at Medical University of South Carolina · NIH-10913480 · Data updated 2026-11-12

This study is looking at a new small molecule that might help lower cholesterol by blocking an enzyme in the liver, and it's designed for people who want to understand how this treatment could help reduce cholesterol and prevent fat buildup in the liver.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$512,957
NIH project number5R01DK136328-02
Project IDNIH-10913480 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from hypercholesterolemia or liver steatosis.

Less likely to help

Patients with normal cholesterol levels or those not affected by liver fat accumulation may not benefit from this research.

What this research studies

This research investigates a novel small molecule that inhibits a specific enzyme in the liver, potentially leading to reduced cholesterol production. Using a platform derived from human stem cells, the researchers aim to understand how this molecule works at a molecular level and its effects on cholesterol levels. The study will involve laboratory tests and humanized mouse models to evaluate the effectiveness of the treatment in lowering cholesterol and preventing fat accumulation in the liver.

Why it matters

Potential benefit: If successful, this research could provide a new treatment option for patients with high cholesterol and liver fat accumulation.

How similar studies have gone: Previous research has shown promise in targeting similar pathways for cholesterol reduction, indicating potential for success with this novel approach.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Duncan, Stephen a — Medical University of South Carolina
  • Study coordinator: Duncan, Stephen a

Related research

Other NIH-funded projects on the same topics.

  • Il1rapl2’s role in shaping cortical wiring in autism

    This project studies how a brain gene linked to autism helps form the connections in deep-layer neurons to understand why circuits develop differently in ASD.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11686533

  • Neuron-OPC Synaptic Mechanisms Shaping Myelin in Health and Disease

    This project looks at how brain cells called oligodendrocyte precursor cells (OPCs) listen to neurons to shape myelin, with potential relevance for autism and related conditions.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11686448

  • Synaptic development and sleep-related brain circuits in autism

    A study in mice explores how early brain circuits that help sleep become wired, hoping to understand sleep problems in autism.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11686419

  • Enteric neuron and intestinal stem cell signals shaping gut barrier

    A research project from the Medical University of South Carolina explores how nerve cells in the gut talk to the lining and stem cells to defend the digestive tract, using human organoids and mouse models.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11623911

  • Glutamine and macrophage behavior in liver cancer

    A funded project at a medical university aims to understand how the liver’s immune cells interact with a specific type of liver cancer by looking at metabolism, especially glutamine and ammonia.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11623910

  • Glycoprotein urine markers that signal lupus nephritis treatment response

    A novel test uses urine glycoprotein patterns to show how well lupus nephritis is responding to standard treatment.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11550186

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.